{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T01:49:44Z","timestamp":1766627384481,"version":"3.45.0"},"reference-count":194,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/12\/429762","PG\/17\/2532884","RE\/13\/5\/30177","RE\/18\/6\/34217"],"award-info":[{"award-number":["CH\/12\/429762","PG\/17\/2532884","RE\/13\/5\/30177","RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["COV\/GLA\/20\/04"],"award-info":[{"award-number":["COV\/GLA\/20\/04"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["CS\/16\/1\/31878","MR\/M016560\/1","PG\/12\/85\/29925"],"award-info":[{"award-number":["CS\/16\/1\/31878","MR\/M016560\/1","PG\/12\/85\/29925"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cjco.2021.05.020","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:21Z","timestamp":1623801621000},"page":"1257-1272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19"],"prefix":"10.1016","volume":"3","author":[{"given":"Rhian M.","family":"Touyz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus O.E.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linsay","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2021.05.020_bib0001","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic. Available at: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed October 22, 2021."},{"key":"10.1016\/j.cjco.2021.05.020_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cjco.2021.05.020_bib0003","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2020.03.053","article-title":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China","volume":"94","author":"Li","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0007","article-title":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies","volume":"3","author":"Pellicori","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0008","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Circ Physiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/heartjnl-2020-317901","article-title":"Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis","volume":"107","author":"Bae","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2021.05.020_bib0011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0012","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.abb3221","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)","volume":"368","author":"Li","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cjco.2021.05.020_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173656","article-title":"Renin-angiotensin system at the interface of COVID-19 infection","volume":"890","author":"Gul","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14787210.2020.1822737","article-title":"COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up","volume":"19","author":"Tajbakhsh","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cjco.2021.05.020_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.667254","article-title":"The role of renin-angiotensin-aldosterone system in the heart and lung: focus on COVID-19","volume":"12","author":"Mascolo","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0019","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","article-title":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study","volume":"108","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0020","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","volume":"5","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-021-01286-7","article-title":"Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte","volume":"20","author":"D'Onofrio","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0022","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0023","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/Mas axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0024","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0025","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjco.2021.05.020_bib0026","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.106.084848","article-title":"Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells","volume":"50","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.05.020_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1-7), and Mas: the other side of the coin","volume":"365","author":"Bader","year":"2013","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.cjco.2021.05.020_bib0028","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es e Silva","year":"2013","journal-title":"Bri J Pharm"},{"key":"10.1016\/j.cjco.2021.05.020_bib0029","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/CS20200363","article-title":"ACE2 the Janus-faced protein\u2014from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19","volume":"134","author":"Touyz","year":"2020","journal-title":"Clin Sci"},{"key":"10.1016\/j.cjco.2021.05.020_bib0031","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cjco.2021.05.020_bib0032","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cjco.2021.05.020_bib0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjco.2021.05.020_bib0034","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0035","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjco.2021.05.020_bib0036","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1016\/j.csbj.2020.11.032","article-title":"ACE2 partially dictates the host range and tropism of SARS-CoV-2","volume":"18","author":"Gao","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0037","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cjco.2021.05.020_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20138","article-title":"Persistent infection of SARS coronavirus in colonic cells in vitro","volume":"74","author":"Chan","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0039","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.120.052824","article-title":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells","volume":"143","author":"McCracken","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0040","article-title":"Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection","volume":"296","author":"Fuentes-Prior","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjco.2021.05.020_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cjco.2021.05.020_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2020.107228","article-title":"Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease","volume":"47","author":"Geng","year":"2020","journal-title":"Cardio Pathol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0043","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s15010-020-01424-5","article-title":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights","volume":"48","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.cjco.2021.05.020_bib0044","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cjco.2021.05.020_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0046","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cjco.2021.05.020_bib0047","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"The science underlying COVID-19: implications for the cardiovascular system","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0048","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0049","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"RECOVERY Collaborative Group; Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173854","article-title":"Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic","volume":"894","author":"Noreen","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0052","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intens Care Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0053","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","article-title":"Oxidative stress, inflammation, and vascular aging in hypertension","volume":"70","author":"Guzik","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.05.020_bib0054","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cjco.2021.05.020_bib0056","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","article-title":"Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection","volume":"51","author":"Delgado-Roche","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0057","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0058","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijid.2020.07.016","article-title":"Mortality in COVID-19 disease patients: correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants","volume":"98","author":"de Sousa","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0059","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/JLB.5COVR0620-306R","article-title":"BTK\/ITK dual inhibitors: modulating immunopathology and lymphopenia for COVID-19 therapy","volume":"109","author":"McGee","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0060","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cjco.2021.05.020_bib0061","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/cvr\/cvy202","article-title":"Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-\/-mice","volume":"115","author":"Gast","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0062","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/cvr\/cvz085","article-title":"Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients","volume":"115","author":"Gast","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0063","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/cvr\/cvaa160","article-title":"Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab","volume":"116","author":"Wenzel","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0064","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study","volume":"143","author":"Pellegrini","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cjco.2020.05.005","article-title":"COVID-19 and myocarditis: what do we know so far?","volume":"2","author":"Pirzada","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2021.05.020_bib0066","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","article-title":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes","volume":"116","author":"Bojkova","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0067","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \"storm\" and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.cjco.2021.05.020_bib0068","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fcvm.2019.00064","article-title":"Myocarditis in humans and in experimental animal models","volume":"6","author":"Blyszczuk","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0069","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0070","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0071","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2021.02.009","article-title":"Coronavirus disease-19: the multi-level, multi-faceted vasculopathy","volume":"322","author":"Quinaglia","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19\u2014a vascular disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0073","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0074","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2- specific immune memory persists after mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cjco.2021.05.020_bib0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.cjco.2021.05.020_bib0076","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0077","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","article-title":"Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis","volume":"81","author":"Zuin","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.cjco.2021.05.020_bib0078","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.120.16472","article-title":"Association between blood pressure control and coronavirus disease 2019 outcomes in 45,418 symptomatic patients with hypertension: an observational cohort study","volume":"77","author":"Sheppard","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.05.020_bib0079","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2021.05.020_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0081","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jch.14146","article-title":"Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: a retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital","volume":"23","author":"Sun","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjco.2021.05.020_bib0082","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cjco.2021.05.020_bib0083","doi-asserted-by":"crossref","DOI":"10.1038\/s41440-020-00541-w","article-title":"Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China","volume":"43","author":"Ran","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0084","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","article-title":"Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19","volume":"395","author":"Williams","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0085","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/jch.14038","article-title":"Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension","volume":"22","author":"Chen","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjco.2021.05.020_bib0086","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3399\/bjgp20X710849","article-title":"Reduction in face-to-face GP consultations","volume":"70","author":"Gray","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cjco.2021.05.020_bib0087","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(20)31356-8","article-title":"COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England","volume":"396","author":"Mafham","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0088","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3390\/ijerph16224578","article-title":"Trends and inequalities in the health care and hypertension outcomes in China, 2011 to 2015","volume":"16","author":"Zhao","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cjco.2021.05.020_bib0089","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.HYP.35.3.814","article-title":"Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly","volume":"35","author":"van Rossum","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.05.020_bib0090","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0091","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.puhe.2020.09.016","article-title":"Socio-economic status and COVID-19-related cases and fatalities","volume":"189","author":"Hawkins","year":"2020","journal-title":"Public Health"},{"key":"10.1016\/j.cjco.2021.05.020_bib0092","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of social and demographic factors with COVID-19 incidence and death rates in the US","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2021.05.020_bib0093","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0094","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0095","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0096","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0097","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0098","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"Esler","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjco.2021.05.020_bib0099","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cjco.2021.05.020_bib0102","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0103","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2215\/CJN.03530320","article-title":"Sound science before quick judgement regarding RAS blockade in COVID-19","volume":"15","author":"Sparks","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0104","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin ii receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.cjco.2021.05.020_bib0106","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0107","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0108","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2021.05.020_bib0109","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/thoraxjnl-2020-215322","article-title":"Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis","volume":"76","author":"Lee","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.cjco.2021.05.020_bib0110","unstructured":"ESC Council on Hypertension. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Available at: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang. Accessed October 22, 2021."},{"key":"10.1016\/j.cjco.2021.05.020_bib0111","unstructured":"European Society of Hypertension. Statement of the European Society of Hypertension (ESH) on hypertension, renin-angiotensin system (RAS) blockers and COVID-19. Available at:https:\/\/www.eshonline.org\/esh-content\/uploads\/2020\/06\/Statement-ESH-on-Hypertension-RAS-Blockers-and-COVID-19-Update-April-15-2020.pdf. Accessed October 22, 2021."},{"key":"10.1016\/j.cjco.2021.05.020_bib0112","unstructured":"Cohen J, on behalf of NephJC Working Group. NephJC statement on SARS-CoV-2 virus, COVID-19, and ACEi\/ARB treatment. Available at:https:\/\/www.era-edta.org\/en\/wp-content\/uploads\/2020\/03\/ERA-EDTA-NephJC-Statement-on-ACEis-and-ARBs-in-COVID-19.pdf. Accessed October 22, 2021."},{"key":"10.1016\/j.cjco.2021.05.020_bib0113","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1001\/jama.2020.23422","article-title":"Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19","volume":"324","author":"Piazza","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2021.05.020_bib0114","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID-19-associated coagulopathy: an exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0115","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/S2352-3026(20)30151-4","article-title":"COVID-19 coagulopathy: an evolving story","volume":"7","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0116","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cjco.2021.05.020_bib0117","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/bjh.16797","article-title":"Dynamic relationship between D-dimer and COVID-19 severity","volume":"190","author":"Li","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0118","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cjco.2021.05.020_bib0121","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ejim.2015.08.017","article-title":"Thromboembolic events in patients with severe pandemic influenza A\/H1N1","volume":"26","author":"Avnon","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0122","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12916-020-01816-2","article-title":"Cardiovascular implications of COVID-19 versus influenza infection: a review","volume":"18","author":"Khan","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2020.10.075","article-title":"Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19","volume":"231","author":"Smilowitz","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0124","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cjco.2021.05.020_bib0125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0126","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.05.020_bib0127","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0128","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0130","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/ATVBAHA.120.314860","article-title":"Endothelial dysfunction and thrombosis in patients with COVID-19-brief report","volume":"40","author":"Nagashima","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0131","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0132","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.cjco.2021.05.020_bib0133","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/blood.2020008086","article-title":"Postdischarge venous thromboembolism following hospital admission with COVID-19","volume":"136","author":"Roberts","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cjco.2021.05.020_bib0134","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2021.05.020_bib0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bjid.2020.07.010","article-title":"Increase in COVID-19 inpatient survival following detection of thromboembolic and cytokine storm risk from the point of admission to hospital by a near real time traffic-light system (TraCe-Tic)","volume":"24","author":"Vizcaychipi","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0136","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0137","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJMc2015630","article-title":"The covid-19 pandemic and the incidence of acute myocardial infarction","volume":"383","author":"Solomon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0138","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5694\/mja2.50769","article-title":"Fewer presentations to metropolitan emergency departments during the COVID-19 pandemic","volume":"213","author":"Kam","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.cjco.2021.05.020_bib0139","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237817","article-title":"Community and healthcare system-related factors feeding the phenomenon of evading medical attention for time-dependent emergencies during COVID-19 crisis","volume":"13","author":"Ahmed","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cjco.2021.05.020_bib0140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/clc.23530","article-title":"Clinical significance of coronavirus disease 2019 (COVID-19) in hospitalized patients with myocardial injury","volume":"44","author":"Briscoe","year":"2021","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0141","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","article-title":"SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome","volume":"4","author":"Dolhnikoff","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.cjco.2021.05.020_bib0142","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0143","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11739-021-02635-w","article-title":"Myocarditis in COVID-19 patients: current problems","volume":"16","author":"Mele","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0144","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10456-020-09753-7","article-title":"Microvascular dysfunction in COVID-19: the MYSTIC study","volume":"24","author":"Rovas","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0146","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0147","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0148","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/cvr\/cvaa209","article-title":"The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study","volume":"116","author":"Mangion","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0149","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001360","article-title":"Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review","volume":"7","author":"Hegde","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.cjco.2021.05.020_bib0150","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/jmv.26581","article-title":"SARS-CoV-2 triggered takotsubo in 38 patients","volume":"93","author":"Finsterer","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0151","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hrthm.2021.01.018","article-title":"Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection","volume":"18","author":"Mountantonakis","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2021.05.020_bib0152","first-page":"10133","article-title":"Predictors and prognostic implications of cardiac arrhythmias in patients hospitalized for COVID-19","author":"Zylla","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0153","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/fca-2020-0082","article-title":"Sudden cardiac death in COVID-19 patients, a report of three cases","volume":"17","author":"Shirazi","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0154","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10741-020-10037-x","article-title":"Mechanisms of COVID-19-induced heart failure: a short review","volume":"26","author":"Adeghate","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2210","article-title":"Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings","author":"Hadzibegovic","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2021.05.020_bib0156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-020-10008-2","article-title":"Heart failure and COVID-19","volume":"26","author":"Bader","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjco.2021.05.020_bib0157","unstructured":"International Society of Heart and Lung Transplantation. Guidance for cardiothoracic transplant and ventricular assist device centers regarding the SARS CoV-2 pandemic. Available at: https:\/\/ishlt.org\/ishlt\/media\/documents\/SARS-CoV-2_-Guidance-for-Cardiothoracic-Transplant-and-VAD-centers.pdf. Accessed April 27, 2020."},{"key":"10.1016\/j.cjco.2021.05.020_bib0158","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.13326","article-title":"Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis","author":"Gaudriot","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjco.2021.05.020_bib0159","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0161","first-page":"1","article-title":"Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients","author":"Palaiodimos","year":"2020","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.cjco.2021.05.020_bib0162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eprac.2020.12.015","article-title":"Hyperglycemia is associated with increased mortality in critically ill patients with COVID-19","volume":"27","author":"Mazori","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cjco.2021.05.020_bib0163","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(20)30315-6","article-title":"COVID-19 and diabetes: a co-conspiracy (editorial)?","volume":"8","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0164","article-title":"The impact of diabetes mellitus in COVID-19: a mechanistic review of molecular interactions","volume":"5436832","author":"Yaribeygi","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.cjco.2021.05.020_bib0166","unstructured":"PHOSP-COVID. The Post-hospitalization COVID-19 Study (PHOSP-COVID). Available at: https:\/\/www.phosp.org\/. Accessed October 22, 2021."},{"key":"10.1016\/j.cjco.2021.05.020_bib0167","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with covid-19","volume":"383","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0168","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2020050615","article-title":"AKI in hospitalized patients with COVID-19","volume":"32","author":"Chan","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0169","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2020060897","article-title":"AKI treated with renal replacement therapy in critically ill patients with COVID-19","volume":"32","author":"Gupta","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2215\/CJN.09610620","article-title":"Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19","volume":"16","author":"Bowe","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0171","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003406","article-title":"Acute kidney injury associated with COVID-19: a retrospective cohort study","volume":"17","author":"Kolhe","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0173","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1681\/ASN.2020040509","article-title":"AKI in hospitalized patients with and without COVID-19: a comparison study","volume":"31","author":"Fisher","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0174","doi-asserted-by":"crossref","first-page":"m4677","DOI":"10.1136\/bmj.m4677","article-title":"Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study","volume":"371","author":"Xie","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cjco.2021.05.020_bib0175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(20)31759-1","article-title":"SARS-CoV-2 renal tropism associates with acute kidney injury","volume":"396","author":"Braun","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.05.020_bib0176","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","volume":"17","author":"Perico","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0177","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.ajkd.2020.05.004","article-title":"Kidney infarction in patients with COVID-19","volume":"76","author":"Post","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjco.2021.05.020_bib0178","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0179","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjco.2021.05.020_bib0181","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1681\/ASN.2020050683","article-title":"Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19","volume":"31","author":"Golmai","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0182","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.2020050699","article-title":"COVID-19-associated kidney injury: a case series of kidney biopsy findings","volume":"31","author":"Sharma","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0183","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2020060802","article-title":"Kidney biopsy findings in patients with COVID-19","volume":"31","author":"Kudose","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0184","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jmv.26552","article-title":"COVID-19, fatigue, and dysautonomia","volume":"93","author":"Lo","year":"2021","journal-title":"Med Virol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0185","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2020.12.007","article-title":"The possible association between COVID-19 and postural tachycardia syndrome","volume":"18","author":"Goldstein","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2021.05.020_bib0186","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12026-021-09185-5","article-title":"Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients","volume":"69","author":"Blitshteyn","year":"2021","journal-title":"Immunol Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0187","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.624968","article-title":"COVID-19 Dysautonomia","volume":"12","author":"Goodman","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0188","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10286-021-00798-2","article-title":"Long-COVID postural tachycardia syndrome: an American Autonomic Society statement","volume":"31","author":"Raj","year":"2021","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.cjco.2021.05.020_bib0189","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/eurheartj\/ehaa280","article-title":"CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic","volume":"41","author":"Linschoten","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.05.020_bib0190","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0040-1715798","article-title":"Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology\/Vascular Medicine","volume":"120","author":"Gerotziafas","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjco.2021.05.020_bib0191","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0040-1710019","article-title":"Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines","volume":"120","author":"Zhai","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjco.2021.05.020_bib0192","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.carrev.2020.05.040","article-title":"Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic","volume":"21","author":"Khan","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cjco.2021.05.020_bib0193","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2021.05.020_bib0194","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.2021.0107","article-title":"Researchers investigate what COVID-19 does to the heart","volume":"325","author":"Abbasi","year":"2021","journal-title":"JAMA"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:05:40Z","timestamp":1762902340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X21001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":194,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2589790X21001554"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2021.05.020","relation":{},"ISSN":["2589-790X"],"issn-type":[{"type":"print","value":"2589-790X"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2021.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}